Finerenone for IgA nephropathy patients
Treatments studied
Part of Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether finerenone can help people with IgA nephropathy, a kidney disease. It is for adults with high protein in their urine who are already on standard kidney-protecting medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have IgA nephropathy confirmed by a kidney biopsy.
- You have been taking stable doses of blood pressure or diabetes medications (like ACE inhibitors or SGLT2 inhibitors) for at least 3 months.
- Your blood pressure is below 140/90.
- Your 24-hour urine test shows more than 300 mg of protein (albumin).
- You do not have a kidney transplant, active cancer, liver disease, heart failure with low pumping ability, recent heart attack or stroke, or certain immune system conditions.
- You are not on immune-suppressing drugs, and your kidney function is not severely low (eGFR above 20).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called atrasentan to see if it helps protect kidney function in people with IgA nephropathy, a kidney disease. It may slow down kidney damage and reduce protein in the urine.
This trial tests a new medication for IgA nephropathy, a kidney disease that causes inflammation and protein loss in urine. It aims to see if the drug can safely slow down kidney damage and protect kidney function.
This trial tests a new pill called finerenone to see if it can slow down kidney damage in people with IgA nephropathy, a type of kidney inflammation. If you qualify, you might get finerenone or a placebo, and the study will monitor your kidney health over time.
This trial tests if finerenone can protect kidneys in people with chronic kidney disease who are not taking common blood pressure medications called ACE inhibitors, ARBs, or renin inhibitors. It may help slow kidney damage.
This trial tests if the drug finerenone can help children with IgA vasculitis (HSP nephritis) who have mild protein in their urine. It aims to protect kidney function without using stronger medications like steroids.
This trial tests a medication called finerenone to see if it can lower the amount of protein in your urine, which is a sign of kidney damage. It is for people with type 2 diabetes and chronic kidney disease who are already on standard blood pressure medications.
Hear when a new IgA Nephropathy (IgAN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.